Heidelberg Materials Bangladesh PLC. (DSE:HEIDELBCEM)
253.40
+8.40 (3.43%)
At close: Jul 31, 2025
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 263.61 | 461.79 | 459.41 | -233.44 | 475.28 | -80.84 | Upgrade |
Depreciation & Amortization | 430.9 | 464.77 | 505.16 | 530.92 | 463.11 | 539.65 | Upgrade |
Other Amortization | 19.96 | 13.31 | 13.24 | 13.2 | 1.45 | 0.49 | Upgrade |
Loss (Gain) From Sale of Assets | 9.29 | 2.67 | -1.26 | 8.82 | - | -3.39 | Upgrade |
Other Operating Activities | 23.42 | -51.24 | -50.28 | -145.44 | -132.65 | 16.07 | Upgrade |
Change in Accounts Receivable | -9.47 | 190.25 | 52.48 | -102.75 | 493.55 | 300.97 | Upgrade |
Change in Inventory | 659.35 | -476.82 | 414.08 | 17.27 | -834.57 | 701.79 | Upgrade |
Change in Accounts Payable | -911.91 | 1,077 | 297.89 | -152.69 | 773.79 | 86.63 | Upgrade |
Change in Other Net Operating Assets | 138.76 | 367.13 | -459.83 | 278.78 | -123.76 | -62.47 | Upgrade |
Operating Cash Flow | 623.91 | 2,049 | 1,231 | 214.67 | 1,116 | 1,499 | Upgrade |
Operating Cash Flow Growth | - | 66.45% | 473.38% | -80.77% | -25.53% | 470.91% | Upgrade |
Capital Expenditures | -332.49 | -267.71 | -209.08 | -223.35 | -260.03 | -306.75 | Upgrade |
Sale of Property, Plant & Equipment | -0.03 | 0.58 | 3.63 | 4.05 | 2.78 | 6.5 | Upgrade |
Cash Acquisitions | - | - | - | - | 0.03 | 37.96 | Upgrade |
Other Investing Activities | -0 | -0 | -0 | - | - | 0 | Upgrade |
Investing Cash Flow | -332.51 | -267.13 | -205.45 | -219.31 | -257.23 | -262.28 | Upgrade |
Long-Term Debt Issued | - | - | 3,992 | 313.56 | - | 60 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -272.95 | Upgrade |
Long-Term Debt Repaid | - | -2,856 | -886.14 | -396.67 | -445.11 | -527.76 | Upgrade |
Total Debt Repaid | -2,362 | -2,856 | -886.14 | -396.67 | -445.11 | -800.71 | Upgrade |
Net Debt Issued (Repaid) | -2,362 | -2,856 | 3,106 | -83.11 | -445.11 | -740.71 | Upgrade |
Common Dividends Paid | -75.65 | -141.26 | -135.18 | -68.86 | -142.08 | -1.14 | Upgrade |
Other Financing Activities | - | - | -31.66 | - | -189.14 | - | Upgrade |
Financing Cash Flow | -2,438 | -2,997 | 2,939 | -151.96 | -776.33 | -741.85 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -0 | 0 | - | Upgrade |
Net Cash Flow | -2,146 | -1,215 | 3,965 | -156.6 | 82.64 | 494.77 | Upgrade |
Free Cash Flow | 291.42 | 1,781 | 1,022 | -8.68 | 856.16 | 1,192 | Upgrade |
Free Cash Flow Growth | - | 74.31% | - | - | -28.18% | - | Upgrade |
Free Cash Flow Margin | 2.05% | 12.08% | 5.69% | -0.05% | 5.97% | 10.21% | Upgrade |
Free Cash Flow Per Share | 5.16 | 31.52 | 18.08 | -0.15 | 15.15 | 21.10 | Upgrade |
Cash Interest Paid | 270.54 | 270.54 | 293.17 | 76.82 | 62.89 | 215.84 | Upgrade |
Cash Income Tax Paid | 255.25 | 316.14 | 377.49 | 296.84 | 324.29 | 244.87 | Upgrade |
Levered Free Cash Flow | 276.01 | 1,542 | 987.67 | 382.21 | 660.24 | 1,421 | Upgrade |
Unlevered Free Cash Flow | 382.25 | 1,704 | 1,168 | 430.92 | 698.4 | 1,536 | Upgrade |
Change in Net Working Capital | 14.33 | -1,076 | -329.51 | -111.31 | -76.13 | -1,075 | Upgrade |
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.